New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


ImmunoGen and Gilead team up to target AML

ImmunoGen entered into a clinical collaboration deal with Gilead Sciences Friday to evaluate the safety and efficacy of two drugs that, when used in concert, have the potential to treat AML, a blood disorder biopharma has found challenging to target.